United States · FDA National Drug Code directory
Meclizine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-836_1a8bdae4-1b42-0a1c-e063-6294a90a49aa
- Product NDC
- 71610-836
- Form
- TABLET, CHEWABLE
- Composition / generic term
- Meclizine Hydrochloride
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20201030
- Source listing expiry
- 20261231
Source-listed ingredients
- MECLIZINE HYDROCHLORIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, CHEWABLE in 1 BOTTLE (71610-836-30) · 71610-836-30
- 60 TABLET, CHEWABLE in 1 BOTTLE (71610-836-53) · 71610-836-53
- 90 TABLET, CHEWABLE in 1 BOTTLE (71610-836-60) · 71610-836-60
- 180 TABLET, CHEWABLE in 1 BOTTLE (71610-836-80) · 71610-836-80
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →